Brazil ranks 20th among the 30 countries worldwide with a high burden of tuberculosis (TB), with nearly 70 000 notified cases and 4 400 deaths per year ([@B1], [@B2]). Rio de Janeiro had the fourth-highest TB incidence rate of any capital in the country in 2015, and the highest mortality rate in 2014 ([@B2]).

In Brazil, it is recommended that TB diagnosis and care occur at the primary-level point of entry to health care, with more severe cases referred to hospitals for admission and follow-up ([@B3], [@B4]). However, being diagnosed with TB at an emergency room (ER) is still a common feature, due to access barriers, as reported by Costa et al. ([@B5]), who found that more than 50% of their subjects had been diagnosed at an ER, with 70% admitted to the hospital.

Mortality is one of the health indicators that reflects the relationship between social and biological issues ([@B6]). Studies have shown that individual characteristics such as advanced age, being male, history of TB treatment, alcohol abuse, and mixed or extrapulmonary clinical presentation, as well as the presence of diabetes, HIV, cancer, or other respiratory diseases, may contribute to risk of death from TB. Social conditions such as low educational level and poverty also contribute to poor outcomes ([@B7]--[@B9]).

The type of health care facility where the patient was diagnosed with and/or subsequently treated for TB may be tied to individual characteristics that will influence his/her survival. Patients diagnosed at a hospital or at an ER may differ from those diagnosed at primary care units in terms of access to health care services ([@B5], [@B10]).

Operational health indicators may also reflect the quality of care delivered to TB patients ([@B11]). Health units with better indicators may have a lower mortality rate for the disease compared to units with worse indicators. This assessment allows for identification of modifiable factors that can reduce or help avert death from TB.

The aim of this study was to identify individual- and health services--related factors associated with deaths in subjects diagnosed with TB.

MATERIALS AND METHODS
=====================

A nonconcurrent cohort study was carried out from 1 January to 31 December 2006 in a population of subjects reported as having TB and living in Rio de Janeiro City. Duplicate entries were identified and removed from the data according to the criteria of the Brazilian Ministry of Health ([@B12]). Subjects who were reported as having TB on the same day as their death, or after their death, and people who were incarcerated, were excluded from the analysis.

Patients were passively followed up using probabilistic record linkage combining data for 2006 from the Information System for Notifiable Diseases (*Sistema de Informação de Agravos de Notificação*, SINAN) and data for 2006--2008 from the Mortality Information System (*Sistema de Informações sobre Mortalidade*, SIM). SINAN is the national information system developed by the Brazilian Ministry of Health for collecting mandatory disease reporting data and is the main data source for epidemiological surveillance. The World Health Organization (WHO) estimates that 87% of Brazil\'s TB cases are reported to the system ([@B13]). SIM is the national information system that collects all death certificate data, including cause of death, and has been in place since 1975. In 2012, SIM coverage was 92% nationwide, and 100% in 8 states ([@B14]).

The open-source software OpenRecLink ([@B15]) was used to link the TB surveillance database to the mortality data. Probabilistic record linkage is the combination of data for the same person from two distinct datasets ([@B16]). About 6 986 TB reports and 118 000 death reports were examined. To improve the efficiency of the linkage process, a five-pass blocking strategy was carried out using various indexing keys formed by combining the following fields: name and surname phonetics codes; sex; and year of birth. For each linked record pair, the full name, sex, and date of birth were compared, and a match score was calculated. The final result was the linked records' classification as a "true pair," a "false pair," or a "doubtful pair." Doubtful pairs were sent for clerical revision to determine their final classification ([@B16]).

The study outcome was survival time, defined as the number of days between the date of TB diagnosis reported in SINAN and the date of death reported in SIM, up to two years after TB treatment initiation.

Patient independent variables were: 1) age (\< 15 years old, 15--59 years old, or 60+ years old); 2) sex; 3) HIV-associated TB ("Yes" or "No"); 4) status at TB treatment entry (new case or unknown; readmission due to disease relapse, or after loss to follow-up; or transfer from other health services); and 5) clinical presentation. A stratified analysis was carried out by dividing the patients into four groups by the type of health care facility where they were diagnosed (outpatient facility or hospital) and HIV status (positive or negative).

The variables (indicators) for each outpatient clinic were: 1) proportion of cases with treatment completion, 2) proportion of cases lost to follow-up, 3) proportion of cases that had no information on the TB treatment outcome, 4) proportion of cases for which a sputum smear microscopy was carried out, 5) proportion of cases tested for HIV, and 6) level of health care provided (primary or secondary). These variables were categorized according to parameters provided by the National TB Program, and the spline function was used to investigate other cutoff points of possible interest.

The variables (indicators) for hospitals were: 1) type (general or infectious diseases facility); 2) administrative level/legal status (municipal, state, federal, charity/private, or university hospital); and 3) having an emergency room on site ("Yes" or "No").

Data were examined using the Kaplan-Meier method and differences in survival curves were tested using the log-rank test. A full survival model that included the significant variables from simpler models was further developed using a hierarchical design consisting of distal, intermediate, and proximal variables ([@B11]). Variables at the same hierarchical level were added to the model, beginning with the distal level (variables related to health facilities), and moving up to the proximal level (variables related to individuals/patients); those that did not show statistical significance at α = 0.10 were excluded from the model. Every time a nonsignificant variable was excluded, the coefficients of the models with and without the variable were compared to evaluate the need to maintain the variable in the adjusted model. The final model included variables with *P* \< 0.05 when adjusted for variables at the same and higher levels.

The association between independent covariates and time to death was assessed using the hazard ratio with a 95% confidence interval (CI). The proportionality of hazards and the quality of the adjustment were investigated using the Schoenfeld residuals.

Analyses were performed using the survival library from the open-source R statistical package (version 2.15.3) (R Foundation for Statistical Computing, Vienna, Austria; [www.r-project.org](http://www.r-project.org)).

The study was approved by the Research Ethics Committee of the Institute for Studies in Collective Health at the Federal University of Rio de Janeiro (UFRJ), protocol \#180.005/2012. Because this was a retrospective study based on routine program information, informed consent was not obtained. All data were kept strictly confidential to ensure anonymity.

RESULTS
=======

In 2006, 6 986 TB cases were registered in SINAN as new TB cases or retreatment. Of those cases for 2006, 26 were not diagnosed with TB until their death and were thus excluded from the sample pool to avoid violation of the proportionality assumption; most of these 26 excluded cases were male (73.1%), 15--59 years old (77.0%), and seen at hospitals (80.8%). A total of 74 cases whose diagnoses were modified after notification, 459 people who were incarcerated, and 83 duplicate records were also excluded.

The final study cohort comprised 6 344 individuals; about two-thirds were male and most (about 80%) entered the health facility for TB treatment as new cases. A total of 11.3% had HIV-associated TB, and 799 (12.6%) had died at the time of the analysis ([Table 1](#t1){ref-type="table"}).

###### Characteristics of cohort subjects and health units in study of the effect of inpatient/outpatient care on tuberculosis (TB) treatment outcome, Rio de Janeiro, Brazil, 2006--2008

  Variable                                                  Total                                                                Deaths                 
  --------------------------------------------------------- -------------------------------------------------------------------- -------- ------ ------ ------
  Individuals (*n* = 6 344)                                                                                                               799    12.6   
  Sex                                                                                                                                                   
                                                            Female                                                               2 277    35.9   251    11.0
                                                            Male                                                                 4 067    64.1   548    13.5
  Age (years)                                                                                                                                           
                                                            \< 15                                                                233      3.7    9      3.9
                                                            15--59                                                               5 388    84.9   594    11.0
                                                            ≥ 60                                                                 714      11.3   196    27.5
  Clinical presentation                                                                                                                                 
                                                            Pulmonary                                                            5 100    80.4   605    11.9
                                                            Extrapulmonary                                                       941      14.8   127    13.5
                                                            Mixed                                                                303      4.8    67     22.1
  Status at TB treatment entry                                                                                                                          
                                                            New case + unknown                                                   5 265    83.0   614    11.7
                                                            Relapse                                                              459      7.2    74     16.1
                                                            Readmission after loss to follow-up                                  432      6.8    71     16.4
                                                            Transfer                                                             188      3.0    40     21.3
  HIV-associated TB                                                                                                                                     
                                                            Yes                                                                  717      11.3   214    29.8
                                                            No                                                                   1 934    30.5   143    7.4
                                                            No information available                                             3 693    58.2   442    12.0
  Hospitals (*n* = 1 368)[a](#TFN1){ref-type="table-fn"}                                                                                  335    24.5   
                                                            Administrative level / legal status[a](#TFN1){ref-type="table-fn"}                          
                                                            Municipal                                                            450      33.8   126    28.0
                                                            State                                                                202      15.2   66     32.7
                                                            Federal                                                              303      22.7   70     23.1
                                                            Charity / private                                                    39       2.9    15     38.5
                                                            University hospital                                                  339      25.4   54     15.9
  Type[a](#TFN1){ref-type="table-fn"}                                                                                                                   
                                                            General                                                              914      68.6   248    27.1
                                                            Infectious diseases                                                  419      31.4   83     19.8
  Emergency room available[a](#TFN1){ref-type="table-fn"}                                                                                               
                                                            No                                                                   817      61.3   129    15.8
                                                            Yes                                                                  516      38.7   202    39.1
  Outpatient facilities (*n* = 4 976)                                                                                                     464    9.3    
                                                            Primary care                                                         4 170    83.8   379    9.1
                                                            Secondary care                                                       806      16.2   85     10.5
  \% treatment completed                                                                                                                                
                                                            0--84                                                                4 893    77.1   461    9.4
                                                            ≥ 85                                                                 83       21.3   3      3.6
  \% of cases lost to follow-up                                                                                                                         
                                                            0--5                                                                 114      2.3    5      4.4
                                                            6--10                                                                656      13.2   47     7.2
                                                            11--20                                                               3 038    61.0   290    9.5
                                                            21--100                                                              1 168    23.5   122    10.4
  \% of TB cases tested for HIV                                                                                                                         
                                                            0--60                                                                3 381    67.9   343    10.1
                                                            61--100                                                              1 595    32.1   121    7.6
  \% of cases with a sputum smear microscopy performed                                                                                                  
                                                            0--79                                                                2 308    46.4   219    9.5
                                                            80--89                                                               1 921    38.6   197    10.3
                                                            90--100                                                              747      15.0   48     6.4
  \% of cases with missing treatment outcome                                                                                                            
                                                            0--14                                                                4 692    94.3   446    9.5
                                                            15--100                                                              284      5.7    18     6.3

Source:

Prepared by the authors based on the study results.

There were 35 records (including four deaths) with missing values for hospital-related variables.

Of the 6 344 individuals, 1 368 (21.6%) were admitted to hospitals ([Table 1](#t1){ref-type="table"}). About one-third of these were diagnosed with TB at hospitals with a municipal administrative level / legal status. With regard to type of hospital, about one-third was diagnosed at infectious diseases hospitals (versus general hospitals). About 40% of the admitted patients were at hospitals with emergency services. The remaining 4 976 individuals (78.4% of the cohort) were diagnosed at outpatient facilities---mostly primary care ([Table 1](#t1){ref-type="table"}).

Most individuals were followed up at outpatient facilities (versus hospitals). The large majority of them were seen at facilities that reported TB treatment completion rates \< 85%, \> 5% of TB cases lost to follow-up, and TB case HIV testing rates \< 60%. About half were seen at outpatient facilities that reported giving less than 80% of TB patients a sputum smear microscopy. A small proportion (5.7%) were seen at facilities reporting that for more than 15% of TB patients there was no information about the TB treatment outcome ([Table 1](#t1){ref-type="table"}).

Among subjects without HIV-associated TB who were diagnosed at outpatient clinics, the risk of death was higher in those 1) older than 60 years (adjusted hazard ratio (aHR) = 3.8, 95% CI 2.1--6.8); 2) readmitted to a health care facility due to disease relapse (aHR = 2.2, CI 1.1--4.4), or after being temporarily lost to follow-up (aHR = 2.8, CI 1.3--5.8); and 3) followed up at a secondary care clinic (aHR = 1.7, CI 1.0--3.0) ([Table 2](#t2){ref-type="table"}). Among HIV-positive cases followed up at outpatient clinics, no statistical difference was noted regarding care.

###### Cox regression model for deaths in individuals with and without HIV-associated tuberculosis (TB) followed up at outpatient facilities, Rio de Janeiro, Brazil, 2006--2008

  Variable                       Without HIV-associated TB[a](#TFN2){ref-type="table-fn"}   With HIV-associated TB[b](#TFN3){ref-type="table-fn"}                                                                                                       
  ------------------------------ ---------------------------------------------------------- ------------------------------------------------------- ---- ------ ----------------------------------- ---------------- ----- ---- ------ ---------------- ----------------
  Sex                                                                                                                                                                                                                                                   
                                 Female                                                     571                                                     23   4.0    1.0                                                  104   24   23.1   1.0              
                                 Male                                                       907                                                     49   5.4    1.4 (0.8--2.2)                                       262   63   24.0   1.0 (0.7--1.7)   
  Age (years)                                                                                                                                                                                                                                           
                                 \< 15                                                      28                                                      0    0.0    NA[e](#TFN6){ref-type="table-fn"}   NA               3     1    33.3   1.3 (0.2--9.4)   
                                 15--59                                                     1 341                                                   57   4.3    1.0                                 1.0              358   86   24.0   1.0              
                                 ≥ 60                                                       109                                                     15   13.8   3.4 (1.9--6.0)                      3.8 (2.1--6.8)   5     0    0.0    NA               
  Clinical presentation                                                                                                                                                                                                                                 
                                 Pulmonary                                                  1 242                                                   65   5.2    1.0                                                  237   60   25.3   1.0              
                                 Extrapulmonary                                             182                                                     6    3.3    0.6 (0.3--1.5)                                       95    21   22.1   0.9 (0.5--1.5)   
                                 Mixed                                                      54                                                      1    1.9    0.4 (0.0--2.5)                                       34    6    17.6   0.7 (0.3--1.5)   
  Status at TB treatment entry                                                                                                                                                                                                                          
                                 New case + unknown                                         1 254                                                   50   4.0    1.0                                 1.0              278   64   23.0   1.0              
                                 Relapse                                                    107                                                     10   9.3    2.4 (1.2--4.7)                      2.2 (1.1--4.4)   36    13   36.1   1.6 (0.9--3.0)   
                                 Readmission after loss to follow-up                        90                                                      9    10.0   2.5 (1.2--5.1)                      2.8 (1.3--5.8)   31    9    29.0   1.3 (0.6--2.5)   
                                 Transfer                                                   27                                                      3    11.1   2.8 (0.9--9.0)                      2.9 (0.8--9.2)   21    2    9.5    0.4 (0.1--1.6)   
  Lost to follow-up                                                                                                                                                                                                                                     
                                 No                                                         1 344                                                   62   4.6    1.0                                                  364   87   24.0   1.0              
                                 Yes                                                        134                                                     10   7.5    1.6 (0.8--3.2)                                       2     0    0.0    NA               
  Type of health care unit                                                                                                                                                                                                                              
                                 Primary care                                               1 208                                                   52   4.3    1.0                                 1.0              314   72   22.9   1.0              1.0
                                 Secondary care                                             270                                                     20   7.6    1.8 (1.0--3.0)                      1.7 (1.0--3.0)   52    15   27.5   1.2 (0.7--2.2)   1.2 (0.7--2.7)

Source:

Prepared by the authors based on the study results.

Concordance: 0.674 (CI: 0.616--0.732).

Concordance: 0.52 (CI: 0.48--0.56).

HR: hazard ratio.

CI: confidence interval.

NA: not applicable.

For subjects without HIV-associated TB who were diagnosed at hospitals, the risk of death was higher in those 1) older than 60 years (aHR = 1.9, CI 1.1--3.3) and 2) diagnosed at a hospital with an ER on site (aHR = 2.8, CI 1.8--4.6) ([Table 3](#t3){ref-type="table"}). The HIV-infected subjects who were diagnosed with TB at hospitals had a higher risk of death if 1) they were older than 60 years (aHR = 3.0, CI 1.4--6.4) or 2) the hospital had an ER on site (aHR = 2.7, CI 1.9--3.8) ([Table 3](#t3){ref-type="table"}).

###### Cox regression model for deaths in individuals with and without HIV-associated tuberculosis (TB) admitted at hospitals, Rio de Janeiro, Brazil, 2006--2008

  Variable                                                            Without HIV-associated TB[a](#TFN7){ref-type="table-fn"}   With HIV-associated TB[b](#TFN8){ref-type="table-fn"}                                                                                      
  ------------------------------------------------------------------- ---------------------------------------------------------- ------------------------------------------------------- ---- ------ ----------------- ---------------- ----- ----- ------ ---------------- ----------------
  Sex                                                                                                                                                                                                                                                                       
                                                                      Female                                                     159                                                     22   13.8   1.0                                123   50    40.7   1.0              
                                                                      Male                                                       295                                                     49   16.6   1.2 (0.7--2.0)                     228   77    33.8   0.8 (0.6--1.1)   
  Age (years)                                                                                                                                                                                                                                                               
                                                                      \< 15                                                      42                                                      1    2.4    0.1 (0.0--1.1)    0.2 (0.1--1.4)   16    2     12.5   0.3 (0.1--1.2)   0.3 (0.1--1.4)
                                                                      15--59                                                     351                                                     52   14.8   1.0               1.0              325   118   36.3   1.0              1.0
                                                                      ≥ 60                                                       61                                                      18   29.5   2.1 (1.2--3.6)    1.9 (1.1--3.3)   10    7     70.0   2.7 (1.3--5.8)   3.0 (1.4--6.4)
  Clinical presentation                                                                                                                                                                                                                                                     
                                                                      Pulmonary                                                  357                                                     56   15.7   1.0                                188   67    35.6   1.0              
                                                                      Extrapulmonary                                             65                                                      8    12.3   0.8 (0.4--1.6)                     95    32    33.7   0.9 (0.6--1.4)   
                                                                      Mixed                                                      32                                                      7    21.9   1.5 (0.7--3.3)                     68    28    41.2   1.2 (0.7--1.8)   
  Type of admission                                                                                                                                                                                                                                                         
                                                                      New case + unknown                                         351                                                     50   14.2   1.0                                257   88    34.2   1.0              
                                                                      Relapse                                                    29                                                      7    24.1   1.7 (0.8--3.7)                     47    15    31.9   0.9 (0.5--1.5)   
                                                                      Readmission after loss to follow-up                        35                                                      7    20.0   1.4 (0.6--3.1)                     30    15    50.0   1.6 (0.9--2.7)   
                                                                      Transfer                                                   39                                                      7    17.9   1.3 (0.6--2.8)                     17    9     52.9   1.9 (0.1--3.8)   
  Administrative level/legal status[e](#TFN11){ref-type="table-fn"}                                                                                                                                                                                                         
                                                                      Municipal                                                  199                                                     32   16.1   1.0                                108   49    45.4   1.0              
                                                                      State                                                      90                                                      21   23.3   1.5 (0.9--2.6)                     40    17    42.5   0.9 (0.5--1.5)   
                                                                      Federal                                                    84                                                      11   13.1   0.8 (0.4--1.7)                     96    27    28.1   0.5 (0.3--0.9)   
                                                                      Charity / private                                          4                                                       1    25.0   1.6 (0.2--11.5)                    10    4     40.0   0.9 (0.3--2.5)   
                                                                      University hospital                                        74                                                      6    8.1    0.5 (0.2--1.1)                     96    30    31.3   0.6 (0.4--0.9)   
  Type of hospital[e](#TFN11){ref-type="table-fn"}                                                                                                                                                                                                                          
                                                                      General                                                    178                                                     31   17.4   1.0                                263   101   38.4   1.0              
                                                                      Specialized in TB                                          273                                                     40   14.7   0.8 (0.5--1.3)                     87    26    29.9   0.7 (0.5--1.1)   
  Emergency room available[e](#TFN11){ref-type="table-fn"}                                                                                                                                                                                                                  
                                                                      No                                                         316                                                     32   10.1   1.0               1.0              220   58    26.4   1.0              1.0
                                                                      Yes                                                        135                                                     39   28.9   3.2 (2.0--5.1)    2.8 (1.8--4.6)   130   69    53.1   2.7 (1.9--3.8)   2.7 (1.9--3.8)

Source:

Prepared by the authors based on the study results.

Concordance: 0.679 (CI: 0.617--0.741).

Concordance: 0.651 (CI: 0.607--0.695).

HR: hazard ratio.

CI: confidence interval.

There were three records with missing values for hospital-related variables.

DISCUSSION
==========

It was observed that factors associated with survival in the group of patients followed up at outpatient clinics differed from those associated with this same outcome in patients admitted to hospitals, a difference that was also observed between groups with and without HIV-associated TB.

Patients with advanced age, and those who had been treated for TB previously, and treatment at a secondary-level outpatient clinic, and at hospitals with ERs on site, were associated with patient survival.

Advanced age was strongly associated with mortality from TB and could be a confounder acting on the association of other variables with the outcome. The higher risk of death in elderly people may be related to reduced immunity and/or the increased difficulty in diagnosing TB in older people, because they are more likely to have nonspecific symptoms, which delays the start of treatment ([@B17]). In addition, mortality may be related to the presence of comorbidities, unfavorable living conditions, malnutrition, and difficulties in accessing health services ([@B18], [@B19]). In Brazil, TB is more common among young adults and is not considered a typical disease of the elderly. Given the diagnostic difficulties in older people, the clinical hypothesis of TB in older age groups must be considered and better investigated ([@B20], [@B21]).

In individuals without HIV-associated TB who were followed up in outpatient clinics, death was associated with a history of 1) previous TB treatment; 2) being seen at the secondary level; and 3) comorbidities most likely requiring a more complex approach to the disease. Directly Observed Therapy (DOT) has been cited as an effective strategy for these patients, as treatment adherence is one of the most important aspects of TB control ([@B4]). Currently, with broader coverage of the Family Health Program in Brazilian health care facilities, coverage with DOT, or Directly Observed Treatment, Short Course (DOTS) is expected to increase considerably ([@B22]).

Resistance to TB drugs can increase mortality to the disease ([@B23], [@B24]). In Brazil, patients with drug resistance are monitored in another (non-SINAN) information system, so their TB treatment outcome is eliminated from the main (SINAN) database, where they are then classified as "TB-drug resistant (TB-DR)" cases. During the study period, the results of the drug sensitivity test were not registered in SINAN. Therefore, some cases reported as deaths in this study may have been TB-DR cases.

For individuals with HIV-associated TB who were followed up at outpatient clinics, the severity of a particular health status was more relevant to survival, given that, if they were being seen at outpatient facilities, no association with important predictors for TB, such as age, was found in their record. HIV/AIDS alone has a strong impact on mortality in TB patients because it hinders early diagnosis, changes the classic presentation of the chest x-ray, and increases the probability of both relapse ([@B25]) and loss to follow-up, due to treatment side effects ([@B26]--[@B28]).

Of the operational indicators related to TB care at outpatient clinics, none was found to be associated with survival, which suggests that the organization of a health program does not have an effect on mortality from all causes. Although these indicators could not explain mortality, they may be important in explaining treatment adherence, a crucial factor for TB cure. One hypothesis would be that the severity of the case could be related to other comorbidities, or to delays in diagnosis and/or treatment ([@B7], [@B18], [@B19], [@B23]). Admission to a hospital with an ER on site was a highly relevant risk predictor for death, suggesting there can be barriers to accessing care and to adequate and timely treatment at the outpatient clinics, as would be expected due to certain limitations at these facilities versus hospitals. The start of treatment could therefore be delayed, possibly leading to a more severe case of TB, which, in turn, would increase the chance of complications that could affect mortality ([@B29]).

This analysis did not include certain health care service variables that could be related to outpatient facilities, and could affect TB treatment outcome, such as 1) delays in diagnosis and treatment that could result from limited business hours at these facilities; 2) difficulties in performing high-complexity tests at these facilities to confirm diagnosis, or services being located far from patients' homes; 3) barriers to accessing care for complications arising during treatment at these facilities ([@B10], [@B30]); and 4) limited experience of some outpatient staff in clinical diagnosis, especially in the absence of classic symptoms of the disease, or in the presence of comorbidities, such as HIV/AIDS and diabetes ([@B5], [@B31]). Further studies are needed to test those hypotheses.

There was a high frequency of individuals without HIV-associated TB admitted to hospitals with emergency services, reinforcing the hypothesis described above. Nonetheless, it is possible that admission to a hospital with emergency services could be an indicator of severity. In a study that analyzed factors related to the delay in seeking health care and diagnosis in metropolitan Rio de Janeiro, Costa et al. ([@B5]) found that 84% of individuals with TB admitted to hospitals were admitted through an ER. Of those who were diagnosed at the time of admission, 79.7% remained hospitalized at the emergency facility or were transferred to another hospital.

In individuals with HIV/AIDS, admission to a hospital with emergency services suggests that the disease had not been previously diagnosed or that there were complications in the treatment for HIV/AIDS. Reference hospitals for the treatment of HIV/AIDS, such as federal and university hospitals, would certainly have treated these patients when they were affected by TB.

The results of this study warrant a deeper investigation of the reasons behind the suggested predictors, such as barriers to accessing timely diagnosis and, thus, appropriate and timely TB treatment. The number of cases starting treatment at emergency services, and with short survival, pointed to the possibility of delay in diagnosis and treatment initiation. The association between advanced age and risk of death may reinforce this hypothesis, given the difficulty in establishing TB diagnosis in elderly people, due to the presence of comorbidities and overlapping symptoms from other diseases that are common in this age group.

TB-related death is an avoidable event that deserves a thorough investigation to identify its causes, especially those that can be addressed by creating new strategies at the health services level. Health care personnel should be more aware of subjects with severity predictors, such as older people, who deserve more attention.

Limitations
-----------

One limitation of this study was the quality of the data (routine data from national databases). Errors in the record linkage process were another potential limitation but would not introduce bias in the model coefficients as long as no doubtful pair was deemed to be a case of death in the clerical review ([@B15]).

Conclusions
-----------

Strategies focusing on an earlier diagnosis of TB are warranted, especially among the elderly, as this age group had a higher risk of death from the disease. In addition, it is important to reinforce the role of primary care in the prevention, detection, diagnosis, treatment, and monitoring of TB cases.
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